Haemonetics Corporation Deferred Income Tax Expense (Benefit)
Haemonetics Corporation (HAE) reported Deferred Income Tax Expense (Benefit) of $668.00 thousand for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-06
- Haemonetics Corporation deferred income tax expense (benefit) for the quarter ending 2026-06-27 was $668.00K.
- Haemonetics Corporation deferred income tax expense (benefit) for the quarter ending 2026-03-28 was -$20.38M, a 786.30% decline year-over-year.
- Haemonetics Corporation deferred income tax expense (benefit) for the quarter ending 2025-12-27 was -$2.06M.
- Haemonetics Corporation deferred income tax expense (benefit) for the quarter ending 2025-09-27 was -$725.00K.
- Haemonetics Corporation deferred income tax expense (benefit) for fiscal 2026 was -$26.40M.
- Haemonetics Corporation deferred income tax expense (benefit) for fiscal 2025 was -$5.62M.
- Haemonetics Corporation deferred income tax expense (benefit) for fiscal 2024 was -$10.88M, a 288.28% decline from fiscal 2023.
- Haemonetics Corporation deferred income tax expense (benefit) for fiscal 2023 was $5.78M, a 14.49% increase from fiscal 2022.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-27 | $668.00K 10-Q · filed 2026-08-06 | -$19.71M derived: sum of 2 quarters · filed 2026-08-06 | -$21.78M derived: sum of 3 quarters · filed 2026-08-06 | -$22.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-28 | -$20.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | -$22.45M derived: sum of 2 quarters · filed 2026-05-20 | -$23.17M derived: sum of 3 quarters · filed 2026-05-20 | -$26.40M 10-K · filed 2026-05-20 |
| 2025-12-27 | -$2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05 | -$2.79M derived: sum of 2 quarters · filed 2026-02-05 | -$6.02M 10-Q · filed 2026-02-05 | -$3.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-27 | -$725.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | -$3.96M 10-Q · filed 2025-11-06 | -$986.00K derived: sum of 3 quarters · filed 2026-08-06 | -$3.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-28 | -$3.23M 10-Q · filed 2026-08-06 | -$261.00K derived: sum of 2 quarters · filed 2026-08-06 | -$2.68M derived: sum of 3 quarters · filed 2026-08-06 | -$5.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-29 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $553.00K derived: sum of 2 quarters · filed 2026-05-20 | -$1.77M derived: sum of 3 quarters · filed 2026-05-20 | -$5.62M 10-K · filed 2026-05-20 |
| 2024-12-28 | -$2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05 | -$4.74M derived: sum of 2 quarters · filed 2026-02-05 | -$8.59M 10-Q · filed 2026-02-05 | -$14.33M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-09-28 | -$2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | -$6.18M 10-Q · filed 2025-11-06 | -$11.91M derived: sum of 3 quarters · filed 2026-05-20 | -$15.16M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-06-29 | -$3.85M 10-Q · filed 2025-08-07 | -$9.59M derived: sum of 2 quarters · filed 2026-05-20 | -$12.84M derived: sum of 3 quarters · filed 2026-05-20 | |
| 2024-03-30 | -$5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | -$8.98M derived: sum of 2 quarters · filed 2026-05-20 | -$10.88M 10-K · filed 2026-05-20 | |
| 2023-12-30 | -$3.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | -$5.14M 10-Q · filed 2025-02-06 | ||
| 2023-09-30 | -$1.89M 10-Q · filed 2024-11-07 | |||
| 2023-04-01 | $5.78M 10-K · filed 2025-05-21 | |||
| 2022-04-02 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-20 | $4.15M derived: sum of 2 quarters · filed 2024-05-20 | $5.05M 10-K · filed 2024-05-20 | |
| 2022-01-01 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-08 | $2.00M 10-Q · filed 2022-02-08 | ||
| 2021-10-02 | $898.00K 10-Q · filed 2021-11-09 | |||
| 2021-04-03 | -$16.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-22 | -$17.81M derived: sum of 2 quarters · filed 2023-05-22 | -$20.84M 10-K · filed 2023-05-22 | |
| 2020-12-26 | -$922.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-08 | -$3.95M 10-Q · filed 2022-02-08 | ||
| 2020-09-26 | -$3.03M 10-Q · filed 2021-11-09 | |||
| 2020-03-28 | -$6.73M 10-K · filed 2022-05-25 | |||
| 2019-03-30 | $13.35M 10-K · filed 2021-05-26 | |||
| 2018-03-31 | -$5.83M 10-K · filed 2020-05-20 | |||
| 2017-04-01 | -$6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-22 | -$6.80M 10-K · filed 2019-05-22 | ||
| 2016-12-31 | $0.00 10-Q · filed 2017-02-06 | |||
| 2016-04-02 | $6.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-23 | -$1.03M derived: sum of 2 quarters · filed 2018-05-23 | -$1.03M 10-K · filed 2018-05-23 | |
| 2015-12-26 | -$7.09M 10-Q · filed 2016-02-02 | -$7.09M 10-Q · filed 2017-02-06 | ||
| 2015-03-28 | $4.23M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-24 | $4.23M 10-K · filed 2017-05-24 | ||
| 2014-12-27 | $0.00 10-Q · filed 2016-02-02 | |||
| 2014-03-29 | -$202.00K 10-K · filed 2016-06-01 | |||
| 2013-03-30 | $589.00K 10-K · filed 2015-05-22 | |||
| 2012-09-29 | $460.00K 10-Q · filed 2012-11-07 | |||
| 2012-03-31 | $5.88M 10-K · filed 2014-05-22 | |||
| 2011-10-01 | $0.00 10-Q · filed 2012-11-07 | |||
| 2011-04-02 | $5.78M 10-K · filed 2013-05-20 | |||
| 2010-04-03 | $2.59M 10-K · filed 2012-05-22 | |||
| 2009-03-28 | $1.65M 10-K · filed 2011-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |